1. Wallace, MC, Preen, D, Jeffrey, GP, et al. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol 2015;9:765–779.
Google Scholar |
Crossref |
Medline2. Kole, C, Charalampakis, N, Tsakatikas, S, et al. Immunotherapy for hepatocellular carcinoma: a 2021 update. Cancers (Basel) 2020;12:2859.
Google Scholar |
Crossref3. Seymour, L, Bogaerts, J, Perrone, A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 2017;18:e143–e152.
Google Scholar |
Crossref |
Medline |
ISI4. Le Bihan, D, Breton, E, Lallemand, D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497–505.
Google Scholar |
Crossref |
Medline |
ISI5. Zhu, L, Cheng, Q, Luo, W, et al. A comparative study of apparent diffusion coefficient and intravoxel incoherent motion-derived parameters for the characterization of common solid hepatic tumors. Acta Radiol 2015;56:1411–1418.
Google Scholar |
SAGE Journals |
ISI6. Zhang, Y, Kuang, S, Shan, Q, et al. Can IVIM help predict HCC recurrence after hepatectomy? Eur Radiol 2019;29:5791–5803.
Google Scholar |
Crossref |
Medline7. Wu, L, Xu, P, Rao, S, et al. ADCtotal ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma. J Magn Reson Imaging 2017;46:820–830.
Google Scholar |
Crossref |
Medline8. Just, N . Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 2014;111:2205–2213.
Google Scholar |
Crossref |
Medline9. Shi, G, Han, X, Wang, Q, et al. Evaluation of multiple prognostic factors of hepatocellular carcinoma with intra-voxel incoherent motions imaging by extracting the histogram metrics. Cancer Manag Res 2020;12:6019–6031.
Google Scholar |
Crossref |
Medline10. Rizell, M, Sternby Eilard, M, Andersson, M, et al. Phase 1 trial with the cell-based immune primer ilixadencel, alone, and combined with sorafenib, in advanced hepatocellular carcinoma. Front Oncol 2019;9:19.
Google Scholar |
Crossref |
Medline11. EASL, EORTC . EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908–943.
Google Scholar |
Crossref |
Medline12. Lencioni, R, Llovet, JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52–60.
Google Scholar |
Crossref |
Medline |
ISI13. Rueckert, D, Sonoda, LI, Hayes, C, et al. Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 1999;18:712–721.
Google Scholar |
Crossref |
Medline |
ISI14. Gustafsson, O, Montelius, M, Starck, G, et al. Impact of prior distributions and central tendency measures on Bayesian intravoxel incoherent motion model fitting. Magn Reson Med 2018;79:1674–1683.
Google Scholar |
Crossref |
Medline15. Llovet, JM, Lencioni, R. mRECIST for HCC: performance and novel refinements. J Hepatol 2020;72:288–306.
Google Scholar |
Crossref |
Medline16. Shropshire, EL, Chaudhry, M, Miller, CM, et al. LI-RADS treatment response algorithm: performance and diagnostic accuracy. Radiology 2019;292:226–234.
Google Scholar |
Crossref |
Medline17. El-Khoueiry, AB, Sangro, B, Yau, T, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017;389:2492–2502.
Google Scholar |
Crossref |
Medline |
ISI18. Yang, X, Xiao, X, Lu, B, et al. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI. Acta Radiol 2019;60:569–577.
Google Scholar |
SAGE Journals |
ISI19. Lee, EY, Hui, ES, Chan, KK, et al. Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers. J Magn Reson Imaging 2015;42:454–459.
Google Scholar |
Crossref |
Medline |
ISI20. Woo, S, Lee, JM, Yoon, JH, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology 2014;270:758–767.
Google Scholar |
Crossref |
Medline |
ISI21. Xu, XQ, Choi, YJ, Sung, YS, et al. Intravoxel incoherent motion MR imaging in the head and neck: correlation with dynamic contrast-enhanced MR imaging and diffusion-weighted imaging. Korean J Radiol 2016;17:641–649.
Google Scholar |
Crossref |
Medline22. Hectors, SJ, Wagner, M, Besa, C, et al. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI? J Magn Reson Imaging 2016;44:856–864.
Google Scholar |
Crossref |
Medline23. Hectors, SJ, Lewis, S, Kennedy, P, et al. Assessment of hepatocellular carcinoma response to (90)Y radioembolization using dynamic contrast material-enhanced MRI and intravoxel incoherent motion diffusion-weighted imaging. Radiol Imaging Cancer 2020;2:e190094.
Google Scholar |
Crossref |
Medline24. Song, YS, Park, CM, Lee, SM, et al. Reproducibility of histogram and texture parameters derived from intravoxel incoherent motion diffusion-weighted MRI of FN13762 rat breast carcinomas. Anticancer Res 2014;34:2135–2144.
Google Scholar |
Medline25. Hayano, K, Fuentes-Orrego, JM, Sahani, DV. New approaches for precise response evaluation in hepatocellular carcinoma. World J Gastroenterol 2014;28:3059–3068.
Google Scholar |
Crossref26. Tam, HH, Collins, DJ, Brown, G, et al. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis. Br J Radiol 2013;86:20130281.
Google Scholar |
Crossref |
Medline27. Sinkus, R, Van Beers, BE, Vilgrain, V, et al. Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development. Eur J Cancer 2012;48:425–431.
Google Scholar |
Crossref |
Medline28. Le Bihan, D . What can we see with IVIM MRI? NeuroImage 2019;187:56–67.
Google Scholar |
Crossref |
Medline29. Kakite, S, Dyvorne, H, Besa, C, et al. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0 T. J Magn Reson Imaging 2015;41:149–156.
Google Scholar |
Crossref |
Medline30. Chevallier, O, Zhou, N, He, J, et al. Removal of evidential motion-contaminated and poorly fitted image data improves IVIM diffusion MRI parameter scan-rescan reproducibility. Acta Radiol 2018;59:1157–1167.
Google Scholar |
SAGE Journals |
ISI31. Li, YT, Cercueil, JP, Yuan, J, et al. Liver intravoxel incoherent motion (IVIM) magnetic resonance imaging: a comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation. Quant Imaging Med Surg 2017;7:59–78.
Google Scholar |
Crossref |
Medline32. Guyader, JM, Bernardin, L, Douglas, NH, et al. Influence of image registration on apparent diffusion coefficient images computed from free-breathing diffusion MR images of the abdomen. J Magn Reson Imaging 2015;42:315–330.
Google Scholar |
Crossref |
Medline33. Barbieri, S, Donati, OF, Froehlich, JM, et al. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magn Reson Med 2016;75:2175–2184.
Google Scholar |
Crossref |
Medline34. Wang, YXJ, Li, YT, Chevallier, O, et al. Dependence of intravoxel incoherent motion diffusion MR threshold b-value selection for separating perfusion and diffusion compartments and liver fibrosis diagnostic performance. Acta Radiol 2019;60:3–12.
Google Scholar |
SAGE Journals |
ISI35. Aliotta, E, Wu, HH, Ennis, DB. Convex optimized diffusion encoding (CODE) gradient waveforms for minimum echo time and bulk motion-compensated diffusion-weighted MRI. Magn Reson Med 2017;77:717–729.
Google Scholar |
Crossref |
Medline36. Wang, YXJ . Observed paradoxical perfusion fraction elevation in steatotic liver: an example of intravoxel incoherent motion modeling of the perfusion component constrained by the diffusion component. NMR Biomed 2021;34:e4488.
Google Scholar |
Crossref |
Medline
Comments (0)